New Zealand markets closed

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.07-0.07 (-1.36%)
At close: 04:00PM EDT
5.06 -0.01 (-0.20%)
After hours: 04:06PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 135.97M
Enterprise value 58.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.65
Price/book (mrq)8.16
Enterprise value/revenue 5.89
Enterprise value/EBITDA -0.37

Trading information

Stock price history

Beta (5Y monthly) 1.78
52-week change 363.17%
S&P500 52-week change 325.01%
52-week high 38.17
52-week low 32.09
50-day moving average 36.19
200-day moving average 34.74

Share statistics

Avg vol (3-month) 3213.47k
Avg vol (10-day) 3197.55k
Shares outstanding 526.45M
Implied shares outstanding 626.82M
Float 811.26M
% held by insiders 11.08%
% held by institutions 181.58%
Shares short (28 Mar 2024) 41.82M
Short ratio (28 Mar 2024) 49.18
Short % of float (28 Mar 2024) 47.19%
Short % of shares outstanding (28 Mar 2024) 46.89%
Shares short (prior month 29 Feb 2024) 41.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 319 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-6,996.11%

Management effectiveness

Return on assets (ttm)-38.32%
Return on equity (ttm)-227.95%

Income statement

Revenue (ttm)9.94M
Revenue per share (ttm)0.35
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -124.25M
Net income avi to common (ttm)-164.57M
Diluted EPS (ttm)-5.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.53M
Total cash per share (mrq)5.27
Total debt (mrq)62.08M
Total debt/equity (mrq)372.55%
Current ratio (mrq)3.95
Book value per share (mrq)0.63

Cash flow statement

Operating cash flow (ttm)-109.71M
Levered free cash flow (ttm)-66.66M